OpenEvidence valuation, funding and investors

OpenEvidence works in medical information search engine development, based in Miami, United States. Founded in 2018, it has about 140 employees.

Tech Companies Series D

VALUATION · TODAY

$14.17B +15% after Series D

Range $10.43B – $18.67B · Grade A

TODAY

+12 MO

$5.00B

$10.00B

$15.00B

$20.00B

$25.00B

2019

2020

2021

2022

2023

2024

2025

2026

2027

Series A $75.0M

Series B $210M

Series C $200M

Series D $250M

ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then

HEADCOUNT · TODAY140 employees

+51%6m growth

+94%1y growth

+637%2y growth

100

200

Data from Apr 2023

TODAY

Predicted in 1 yr $16.23B +15% vs today

Predicted next raise $1.79B if a round comes

Winding-down probability 0%

Last round: Series D · $250M · Apr 2026
Valuation at last round: $12.00B
Headcount: 140 · growing
Grade: A
Founded: 2018

How VCMC values companies →

OpenEvidence valuation today

VCMC values OpenEvidence at $14.2B today, with a range of $10.4B to $18.7B and a grade of A. The valuation starts from its last funding round, a Series D round in Apr 2026.

Valuation by date (111 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

OpenEvidence: valuation by date, as the model would have shown it on each date
Date	Valuation	Range	Predicted in 1 yr	Phase	Headcount	Trend	Grade	Winding-down probability
1 Jan 2018	$8.90M	$3.24M – $24.4M	$12.2M (+37%)	before first round	–	unknown	D	0%
1 Feb 2018	$9.14M	$3.33M – $25.1M	$12.5M (+37%)	before first round	–	unknown	D	0%
1 Mar 2018	$9.36M	$3.41M – $25.7M	$12.8M (+37%)	before first round	–	unknown	D	0%
1 Apr 2018	$9.62M	$3.50M – $26.4M	$13.2M (+37%)	before first round	–	unknown	D	0%
1 May 2018	$9.87M	$3.59M – $27.1M	$13.5M (+37%)	before first round	–	unknown	D	0%
1 Jun 2018	$10.1M	$3.69M – $27.8M	$13.9M (+37%)	before first round	–	unknown	D	0%
1 Jul 2018	$10.4M	$3.79M – $28.6M	$14.3M (+37%)	before first round	–	unknown	D	0%
1 Aug 2018	$10.7M	$3.89M – $29.4M	$14.4M (+35%)	before first round	–	unknown	D	0%
1 Sep 2018	$11.0M	$4.00M – $30.2M	$14.5M (+32%)	before first round	–	unknown	D	0%
1 Oct 2018	$11.3M	$4.10M – $30.9M	$14.7M (+30%)	before first round	–	unknown	D	0%
1 Nov 2018	$11.6M	$4.21M – $31.8M	$14.8M (+28%)	before first round	–	unknown	D	0%
1 Dec 2018	$11.9M	$4.32M – $32.6M	$14.9M (+26%)	before first round	–	unknown	D	0%
1 Jan 2019	$12.2M	$4.44M – $33.5M	$15.1M (+24%)	before first round	–	unknown	D	0%
1 Feb 2019	$12.5M	$4.56M – $34.4M	$15.2M (+21%)	before first round	–	unknown	D	0%
1 Mar 2019	$12.8M	$4.67M – $35.3M	$15.3M (+19%)	before first round	–	unknown	D	0%
1 Apr 2019	$13.2M	$4.80M – $36.2M	$15.5M (+17%)	before first round	–	unknown	D	0%
1 May 2019	$13.5M	$4.93M – $37.2M	$15.6M (+15%)	before first round	–	unknown	D	0%
1 Jun 2019	$13.9M	$5.06M – $38.2M	$15.8M (+13%)	before first round	–	unknown	D	0%
1 Jul 2019	$14.3M	$5.19M – $39.2M	$15.9M (+11%)	before first round	–	unknown	D	0%
1 Aug 2019	$14.4M	$5.25M – $39.6M	$16.0M (+11%)	before first round	–	unknown	D	0%
1 Sep 2019	$14.5M	$5.29M – $39.9M	$16.2M (+11%)	before first round	–	unknown	D	0%
1 Oct 2019	$14.7M	$5.34M – $40.3M	$16.3M (+11%)	before first round	–	unknown	D	0%
1 Nov 2019	$14.8M	$5.39M – $40.7M	$16.5M (+11%)	before first round	–	unknown	D	0%
1 Dec 2019	$14.9M	$5.44M – $41.0M	$16.6M (+11%)	before first round	–	unknown	D	0%
1 Jan 2020	$15.1M	$5.49M – $41.4M	$16.8M (+11%)	before first round	–	unknown	D	0%
1 Feb 2020	$15.2M	$5.54M – $41.8M	$16.9M (+11%)	before first round	–	unknown	D	0%
1 Mar 2020	$15.3M	$5.59M – $42.1M	$17.1M (+11%)	before first round	–	unknown	D	0%
1 Apr 2020	$15.5M	$5.64M – $42.5M	$17.2M (+11%)	before first round	–	unknown	D	0%
1 May 2020	$15.6M	$5.69M – $42.9M	$17.4M (+11%)	before first round	–	unknown	D	0%
1 Jun 2020	$15.8M	$5.74M – $43.3M	$17.6M (+11%)	before first round	–	unknown	D	0%
1 Jul 2020	$15.9M	$5.79M – $43.7M	$17.7M (+11%)	before first round	–	unknown	D	0%
1 Aug 2020	$16.1M	$5.84M – $44.1M	$17.9M (+11%)	before first round	–	unknown	D	0%
1 Sep 2020	$16.2M	$5.90M – $44.5M	$18.0M (+11%)	before first round	–	unknown	D	0%
1 Oct 2020	$16.3M	$5.95M – $44.9M	$18.2M (+11%)	before first round	–	unknown	D	0%
1 Nov 2020	$16.5M	$6.00M – $45.3M	$18.4M (+11%)	before first round	–	unknown	D	0%
1 Dec 2020	$16.6M	$6.06M – $45.7M	$18.5M (+11%)	before first round	–	unknown	D	0%
1 Jan 2021	$16.8M	$6.11M – $46.1M	$18.7M (+11%)	before first round	–	unknown	D	0%
1 Feb 2021	$16.9M	$6.17M – $46.5M	$18.8M (+11%)	before first round	–	unknown	D	0%
1 Mar 2021	$17.1M	$6.22M – $46.9M	$19.0M (+11%)	before first round	–	unknown	D	0%
1 Apr 2021	$17.2M	$6.28M – $47.4M	$19.1M (+11%)	before first round	–	unknown	D	0%
1 May 2021	$17.4M	$6.33M – $47.8M	$19.2M (+11%)	before first round	–	unknown	D	0%
1 Jun 2021	$17.6M	$6.39M – $48.2M	$19.4M (+10%)	before first round	–	unknown	D	0%
1 Jul 2021	$17.7M	$6.45M – $48.6M	$19.5M (+10%)	before first round	–	unknown	D	0%
1 Aug 2021	$17.9M	$6.51M – $49.1M	$19.7M (+10%)	before first round	–	unknown	D	0%
1 Sep 2021	$18.0M	$6.57M – $49.5M	$19.8M (+10%)	before first round	–	unknown	D	0%
1 Oct 2021	$18.2M	$6.62M – $50.0M	$20.0M (+10%)	before first round	–	unknown	D	0%
1 Nov 2021	$18.4M	$6.68M – $50.4M	$20.1M (+10%)	before first round	–	unknown	D	0%
1 Dec 2021	$18.5M	$6.74M – $50.9M	$20.3M (+9%)	before first round	–	unknown	D	0%
1 Jan 2022	$18.7M	$6.81M – $51.4M	$20.4M (+9%)	before first round	–	unknown	D	0%
1 Feb 2022	$18.8M	$6.86M – $51.7M	$20.6M (+9%)	before first round	–	unknown	D	0%
1 Mar 2022	$19.0M	$6.90M – $52.1M	$20.7M (+9%)	before first round	–	unknown	D	0%
1 Apr 2022	$19.1M	$6.96M – $52.5M	$20.9M (+9%)	before first round	–	unknown	D	0%
1 May 2022	$19.2M	$7.01M – $52.9M	$21.0M (+9%)	before first round	–	unknown	D	0%
1 Jun 2022	$19.4M	$7.06M – $53.3M	$21.2M (+9%)	before first round	–	unknown	D	0%
1 Jul 2022	$19.5M	$7.11M – $53.7M	$21.3M (+9%)	before first round	–	unknown	D	0%
1 Aug 2022	$19.7M	$7.16M – $54.1M	$21.5M (+9%)	before first round	–	unknown	D	0%
1 Sep 2022	$19.8M	$7.22M – $54.5M	$21.7M (+9%)	before first round	–	unknown	D	0%
1 Oct 2022	$20.0M	$7.27M – $54.9M	$21.8M (+9%)	before first round	–	unknown	D	0%
1 Nov 2022	$20.1M	$7.32M – $55.3M	$22.0M (+9%)	before first round	–	unknown	D	0%
1 Dec 2022	$20.3M	$7.38M – $55.7M	$22.1M (+9%)	before first round	–	unknown	D	0%
1 Jan 2023	$20.4M	$7.43M – $56.1M	$22.3M (+9%)	before first round	–	unknown	D	0%
1 Feb 2023	$20.6M	$7.49M – $56.5M	$22.5M (+9%)	before first round	–	unknown	D	0%
1 Mar 2023	$20.7M	$7.54M – $56.9M	$22.6M (+9%)	before first round	–	unknown	D	0%
1 Apr 2023	$19.3M	$7.04M – $53.1M	$21.1M (+9%)	before first round	10	unknown	D	0%
1 May 2023	$19.5M	$7.09M – $53.5M	$21.3M (+9%)	before first round	10	unknown	D	0%
1 Jun 2023	$19.6M	$7.15M – $53.9M	$21.4M (+9%)	before first round	10	unknown	D	0%
1 Jul 2023	$19.8M	$7.20M – $54.3M	$21.6M (+9%)	before first round	10	unknown	D	0%
1 Aug 2023	$19.9M	$7.25M – $54.7M	$20.9M (+5%)	before first round	10	unknown	D	0%
1 Sep 2023	$20.1M	$7.31M – $55.1M	$20.1M (0%)	before first round	10	unknown	D	0%
1 Oct 2023	$30.2M	$12.9M – $59.9M	$29.6M (-2%)	before first round	16	growing	C	0%
1 Nov 2023	$30.4M	$13.0M – $60.4M	$28.7M (-6%)	before first round	16	growing	C	0%
1 Dec 2023	$30.6M	$13.1M – $60.8M	$27.9M (-9%)	before first round	16	growing	C	0%
1 Jan 2024	$30.8M	$13.2M – $61.3M	$27.1M (-12%)	before first round	16	growing	C	0%
1 Feb 2024	$31.1M	$13.3M – $61.7M	$26.3M (-15%)	before first round	16	growing	C	0%
1 Mar 2024	$32.2M	$13.8M – $63.9M	$26.8M (-17%)	before first round	19	growing	C	0%
1 Apr 2024	$32.4M	$13.9M – $64.4M	$26.1M (-20%)	before first round	19	growing	C	0%
1 May 2024	$32.7M	$14.0M – $64.8M	$25.4M (-22%)	before first round	19	growing	C	0%
1 Jun 2024	$32.9M	$14.1M – $65.3M	$24.7M (-25%)	before first round	19	growing	C	0%
1 Jul 2024	$33.1M	$14.2M – $65.8M	$24.1M (-27%)	before first round	19	growing	C	0%
1 Aug 2024	$32.2M	$13.6M – $64.8M	$23.4M (-27%)	before first round	19	growing	C	0%
1 Sep 2024	$31.4M	$13.1M – $63.9M	$22.8M (-27%)	before first round	19	growing	C	0%
1 Oct 2024	$30.6M	$12.6M – $63.0M	$22.2M (-27%)	before first round	19	growing	C	0%
1 Nov 2024	$26.3M	$8.26M – $62.0M	$19.1M (-27%)	before first round	19	up	D	0%
1 Dec 2024	$25.7M	$7.95M – $61.1M	$18.6M (-27%)	before first round	19	up	D	0%
1 Jan 2025	$25.6M	$7.83M – $61.7M	$18.9M (-26%)	before first round	21	up	D	0%
1 Feb 2025	$1.0B	$869M – $2.1B	$1.8B (+80%)	after a round	21	up	B	0%
2 Feb 2025	$1.0B	$869M – $2.1B	$1.8B (+80%)	after a round	21	up	B	0%
1 Mar 2025	$1.0B	$869M – $2.1B	$1.8B (+72%)	after a round	21	up	B	0%
1 Apr 2025	$1.1B	$869M – $2.1B	$1.8B (+64%)	after a round	21	up	B	0%
1 May 2025	$1.2B	$869M – $2.1B	$1.8B (+56%)	after a round	21	up	B	0%
1 Jun 2025	$1.2B	$869M – $2.1B	$1.8B (+48%)	after a round	21	up	B	0%
1 Jul 2025	$1.4B	$869M – $2.4B	$2.1B (+54%)	after a round	41	growing	B	0%
18 Jul 2025	$3.5B	$3.0B – $6.0B	$5.2B (+50%)	after a round	41	growing	B	0%
1 Aug 2025	$3.6B	$3.0B – $6.0B	$5.2B (+48%)	after a round	41	growing	B	0%
1 Sep 2025	$3.7B	$3.0B – $6.0B	$5.2B (+43%)	after a round	41	growing	B	0%
1 Oct 2025	$3.9B	$3.0B – $6.8B	$5.9B (+52%)	after a round	72	growing	B	0%
21 Oct 2025	$6.0B	$5.2B – $9.0B	$7.8B (+30%)	after a round	72	growing	A	0%
1 Nov 2025	$6.1B	$5.2B – $9.0B	$7.8B (+29%)	after a round	72	growing	A	0%
1 Dec 2025	$6.2B	$5.2B – $9.4B	$8.2B (+31%)	after a round	89	growing	A	0%
1 Jan 2026	$6.4B	$5.2B – $9.5B	$8.3B (+29%)	after a round	93	growing	A	0%
1 Feb 2026	$6.6B	$5.2B – $9.5B	$8.3B (+26%)	after a round	93	growing	A	0%
1 Mar 2026	$6.7B	$5.2B – $9.5B	$8.3B (+23%)	after a round	93	growing	A	0%
1 Apr 2026	$6.9B	$5.2B – $9.5B	$8.3B (+19%)	after a round	93	growing	A	0%
7 Apr 2026	$12.0B	$10.4B – $17.9B	$15.6B (+30%)	after a round	93	growing	A	0%
1 May 2026	$12.2B	$10.4B – $17.9B	$15.6B (+28%)	after a round	117	growing	A	0%
1 Jun 2026	$12.5B	$10.4B – $17.9B	$15.6B (+25%)	after a round	117	growing	A	0%
1 Jul 2026	$12.8B	$10.4B – $17.9B	$15.6B (+22%)	after a round	117	growing	A	0%
1 Aug 2026	$13.1B	$10.4B – $18.1B	$15.8B (+20%)	after a round	123	growing	A	0%
1 Sep 2026	$13.4B	$10.4B – $18.1B	$15.8B (+18%)	after a round	123	growing	A	0%
1 Oct 2026	$13.9B	$10.4B – $18.7B	$16.2B (+17%)	after a round	140	growing	A	0%
24 Oct 2026	$14.2B	$10.4B – $18.7B	$16.2B (+15%)	after a round	140	growing	A	0%

Key facts about OpenEvidence

Founded: 2018
Headquarters: Miami, United States
Employees: about 140 +94% in a year
Total raised: $735M
Funding rounds: 4
Last round: Series D Apr 2026

OpenEvidence was founded in 2018 by Daniel Nadler and Zachary Ziegler.

OpenEvidence funding history

OpenEvidence has 4 funding rounds on record, from Feb 2025 to Apr 2026, $735M in total. The latest disclosed valuation is $12.00B post-money (Series D, Apr 2026).

Series D 6 Apr 2026
Led by Thrive Capital, DST Global; with Sequoia Capital, GV, NVIDIA, Kleiner Perkins, Blackstone, KKR, Coatue, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, Craft Ventures, Goanna, Meritech Capital, Alkeon, Mayo Clinic.
Sources: rockhealth.com, cooley.com, mobihealthnews.com and 5 more
$250M
$12.00B post-money
Series C 20 Oct 2025
Led by GV; with Sequoia Capital, Kleiner Perkins, Thrive Capital, Coatue, Blackstone, BOND, Craft Ventures.
Sources: techfundingnews.com, techcrunch.com, axios.com and 3 more
$200M
$6.00B post-money
Series B 17 Jul 2025
Led by GV, Kleiner Perkins; with Sequoia Capital, Coatue, Conviction, Thrive Capital.
Sources: techfundingnews.com, fiercehealthcare.com, mobihealthnews.com and 2 more
$210M
$3.50B post-money
Series A 1 Feb 2025
Led by Sequoia Capital.
Sources: healthtechnerds.com, cnbc.com, en.wikipedia.org and 2 more
$75M
$1.00B post-money

OpenEvidence investors

19 investors have backed OpenEvidence; Sequoia Capital, GV and Kleiner Perkins and 2 more led at least one round.

What OpenEvidence does

OpenEvidence works in tech companies, with 8 recorded offerings and customers in healthcare.

OpenEvidence Inc. is an American company that develops and operates a medical information platform and artificial intelligence solutions for healthcare professionals. The company provides a medical search engine, clinical decision support tools, and AI-powered clinical consultations, serving healthcare providers, medical researchers, and clinical teams. OpenEvidence is HIPAA compliant and SOC 2 Type II certified, and collaborates with major medical organizations.

Description from Veridion's company data.

Products and services

Medical Information Search Engine Development
Multimedia Medical Content Delivery
Clinical Findings Aggregation and Delivery
Clinical Pathway Guidance Services
Healthcare Professional Verification Services
Medical Information Email Alert Services
Medical Content Partnership Services
Medical Content Licensing Services

Markets

Healthcare

Technology

AI-Powered Medical Search Engine

Business model

Business-to-Business
Software-as-a-Service

Industry codes (NAICS)

513210 Software Publishers 70% match
621399 Offices of All Other Miscellaneous Health Practitioners 30% match

Questions about OpenEvidence

What is OpenEvidence worth?

Valuation $14.2B (range $10.4B to $18.7B), as of 24 Oct 2026. The last disclosed valuation was $12.00B (Series D, Apr 2026).

Has OpenEvidence raised money?

OpenEvidence has 4 funding rounds on record, from Feb 2025 to Apr 2026, $735M in total. The latest disclosed valuation is $12.00B post-money (Series D, Apr 2026).

Who has invested in OpenEvidence?

Sequoia Capital, GV, Kleiner Perkins, Thrive Capital, DST Global and Coatue, and 13 more. Lead investors include Sequoia Capital, GV, Kleiner Perkins and Thrive Capital.

How many people work at OpenEvidence?

About 140, up 94% over the last year. Headcount grew from 10 in Apr 2023 to 140 in Sep 2026.

What does OpenEvidence do?

OpenEvidence works in tech companies, with 8 recorded offerings and customers in healthcare. Its main offerings are medical information search engine development, multimedia medical content delivery and clinical findings aggregation and delivery.

When was OpenEvidence founded, and where is it based?

OpenEvidence was founded in 2018 and is based in Miami, United States. It has about 140 employees, up 94% over the last year.

How we value companies Report an issue